Abstract

Purpose: This study aims to provide a comparison between MCNPX and MIRDcell calculations for self-dose and cross-dose for three therapeutic isotopes used in internal radiotherapy (Lu-177, I-131 and Y-90) and to develop a multi-cellular geometric model to simulate an in vitro scenario.Materials and Methods: The self- and cross-dose to individual cell nuclei were assessed by Monte Carlo N-Particle eXtended (MCNPX). A close-packed cubic cell arrangement was assumed with the same amount of radioactivity per cell. Various cell sizes and subcellular distributions of radioactivity (nucleus, cytoplasm and cell membrane) were simulated. S values were obtained by MIRDcell for comparison. A Python 3.4 program was used to generate random cell coordinates in order to build a complex model that takes certain real conditions (cell size and cluster size) into account.Results: The relative differences of MCNPX versus MIRD S values (Sself) ranged from 2.88 to 10.10% for Lu-177; from 0 to 8.41% for I-131 and from 2.80 to 9.58% for Y-90. The relative differences of MCNPX versus MIRDcell cross-dose S values were 3.6%−15.7% for a sphere. The ratio of Scross max to Sself decreased for Lu-177 and I-131 with increasing cell size. The source localization within the cells had no significant impact on the cross-dosing. For single cells, the subcellular location of the source had an effect on Sself.Conclusions: MCNPX and MIRD cell-calculated S values showed good agreement. The model provided could be used to predict the biological effect caused by emitted radiation from therapeutic radionuclides at the cellular level.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.